Messina, M. P., Rauktys, A., Lee, L., & Dabora, S. L. (2007). Tuberous sclerosis preclinical studies: Timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779. BioMed Central.
Chicago-tyylinen lähdeviittausMessina, Michael P., Aubrey Rauktys, Laifong Lee, ja Sandra L. Dabora. Tuberous Sclerosis Preclinical Studies: Timing of Treatment, Combination of a Rapamycin Analog (CCI-779) and Interferon-gamma, and Comparison of Rapamycin to CCI-779. BioMed Central, 2007.
MLA-viiteMessina, Michael P., Aubrey Rauktys, Laifong Lee, ja Sandra L. Dabora. Tuberous Sclerosis Preclinical Studies: Timing of Treatment, Combination of a Rapamycin Analog (CCI-779) and Interferon-gamma, and Comparison of Rapamycin to CCI-779. BioMed Central, 2007.